psychiatryRounds

Connecting Psychiatry - Expert community for all mental health professionals

AACAP: Investigational Pediatric ADHD Agent Aims at Reduced Abuse Potential

(PSYCHIATRIC TIMES) - MedPage Today Action Points

SAN DIEGO, Oct. 31 -- An investigational d-amphetamine prodrug appears to be effective in treating pediatric attention deficit hyperactivity disorder, with the goal of less abuse potential than amphetamines, researchers said.

All dose levels of lisdexamfetamine (NRP104) were significantly more effective than placebo, said Robert. L. Findling, M.D., of Case Western Reserve in Cleveland, and colleagues, who presented the result of a phase III study at the American Academy of Child and Adolescent Psychiatry meeting.

For full article, please visit:
http://www.psychiatrictimes.com/adhd/article/10168/53241

Views: 3

Comment

You need to be a member of psychiatryRounds to add comments!

Join psychiatryRounds


psychiatryRounds Social Media

Sponsors

CMEinfo: Board Reviews in Anesthesia, Cardiology, Internal Medicine, Radiology

© 2019   Created by PsychiatryRounds Team.   Powered by

Badges  |  Report an Issue  |  Terms of Service